JPH0656689A - Preventing and treating composition for infectious diarrhea - Google Patents

Preventing and treating composition for infectious diarrhea

Info

Publication number
JPH0656689A
JPH0656689A JP4225059A JP22505992A JPH0656689A JP H0656689 A JPH0656689 A JP H0656689A JP 4225059 A JP4225059 A JP 4225059A JP 22505992 A JP22505992 A JP 22505992A JP H0656689 A JPH0656689 A JP H0656689A
Authority
JP
Japan
Prior art keywords
tea extract
diarrhea
chitin
infectious diarrhea
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4225059A
Other languages
Japanese (ja)
Other versions
JP3890086B2 (en
Inventor
Ken Tsuda
憲 津田
Yukiko Nagato
有希子 長戸
Hajime Hatta
一 八田
Yutaka Ogasawara
豊 小笠原
Masaru Fujiki
優 藤木
Busaku Kin
武祚 金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Priority to JP22505992A priority Critical patent/JP3890086B2/en
Publication of JPH0656689A publication Critical patent/JPH0656689A/en
Application granted granted Critical
Publication of JP3890086B2 publication Critical patent/JP3890086B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain a preventing and treating composition for infectious diarrhea capable of feeding a tea extract effective against a pathogen of the infectious diarrhea to the intestinal tract while keeping the activity thereof. CONSTITUTION:This preventing and treating composition for infectious diarrhea comprising chitin containing a tea extract is administered to a human or livestock to effectively prevent or treat viral or bacterial diarrhea.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、茶抽出物を含有するキ
チンを含む感染性下痢症予防及び治療用組成物に関す
る。
TECHNICAL FIELD The present invention relates to a composition for preventing and treating infectious diarrhea, which comprises chitin containing a tea extract.

【0002】[0002]

【従来の技術】下痢症はヒトおよび家畜のありふれた疾
病のひとつであるが、幼弱な個体、特に哺乳期において
は脱水症や他の合併症を引き起こし、重篤な事態に至る
ことが多い。下痢症の原因としては、ウイルスや細菌に
よる感染性のものと環境、ストレス、食餌などによる非
感染性のものに分かれるが、とくに感染性下痢症は他の
個体へ伝播し、集団全体に多大な被害をもたらすことが
多い。
BACKGROUND OF THE INVENTION Diarrhea is one of the common diseases in humans and domestic animals, but often causes severe conditions such as dehydration and other complications in young individuals, especially in the nursing period. . The causes of diarrhea are divided into those that are infectious by viruses and bacteria and those that are non-infectious due to environment, stress, diet, etc. In particular, infectious diarrhea is transmitted to other individuals and causes a large amount in the entire population. It often causes damage.

【0003】感染性下痢症の病原体は、大別してウイル
スと細菌に分けられる。これらの病原体が食物あるいは
飲料とともに経口的に腸管に侵入し、腸粘膜に定着して
増殖することにより発症する。また、2種以上の病原体
が複合感染し、症状をより重篤化することもまれではな
い。
Pathogens of infectious diarrhea are roughly classified into viruses and bacteria. It develops when these pathogens enter the intestinal tract orally along with food or drink, and colonize and grow on the intestinal mucosa. In addition, it is not uncommon for two or more pathogens to undergo multiple infections and to make the symptoms more serious.

【0004】ウイルス性下痢症の病原体としては、ロタ
ウイルス、コロナウイルス、ノーウオークウイルス、カ
リシウイルス、アデノウイルス、アストロウイルスなど
が知られているが、特に哺乳期のヒトあるいは家畜で
は、ロタウイルス性下痢症が問題となっている。ウイル
ス性下痢症に対しては、ワクチンの研究も活発に進めら
れてはいるが、未だ有効なワクチンの成功に至っていな
い。臨床の現場では、専ら、脱水症を防ぐために電解質
と栄養剤を補給するといった対症療法がなされているの
みである。
Rotavirus, coronavirus, nook virus, calicivirus, adenovirus, astrovirus and the like are known as pathogens of viral diarrhea. Diarrhea is a problem. Although active research is being conducted on vaccines against viral diarrhea, effective vaccines have not yet been successful. In the clinical setting, only symptomatic treatments such as supplementation of electrolytes and nutrients to prevent dehydration are performed.

【0005】また、細菌性下痢症の病原体としては、赤
痢菌、サルモネラ菌、病原性大腸菌、毒素原性大腸菌、
コレラ菌、腸炎ビブリオ、エルシニア菌、カンピロバク
ター属、ヘリコバクター属、ブドウ球菌、黄色ブドウ球
菌、緑膿菌などが知られている。これら下痢症を引き起
こす細菌に対しては、通常、抗生物質の投与など化学療
法が施されているが、耐性菌の出現など問題点も多い。
Further, as pathogens of bacterial diarrhea, Shigella, Salmonella, pathogenic E. coli, toxigenic E. coli,
Cholera, Vibrio parahaemolyticus, Yersinia, Campylobacter, Helicobacter, Staphylococcus, Staphylococcus aureus, Pseudomonas aeruginosa and the like are known. Chemotherapy such as administration of antibiotics is usually applied to these diarrhea-causing bacteria, but there are many problems such as emergence of resistant bacteria.

【0006】一方、多くの腸管感染症の病原性細菌に対
し、試験管内で抗菌作用を示す公知の天然物として、茶
が報告されている(日本細菌学雑誌,44,669−6
72,1989年))。また、乳幼児嘔吐下痢症の病原
ウイルスであるロタウイルスに対して、茶の抽出物が試
験管内で感染阻害活性を示すことが報告されている(第
37回日本ウイルス学会総会,1989年)。いずれの
場合も、試験管内において、茶抽出物中に含まれる主と
してポリフェノール化合物が下痢症の病原体の表面に結
合することにより、病原体の活性が低下したものと考え
られている。
On the other hand, tea has been reported as a known natural product showing an antibacterial action in vitro against many pathogenic bacteria of intestinal infectious diseases (Japanese Journal of Bacteriology, 44,669-6).
72, 1989)). In addition, it has been reported that a tea extract exhibits an infection inhibitory activity in vitro against rotavirus, which is a pathogenic virus for infant vomiting diarrhea (37th Annual Meeting of the Japanese Society for Virology, 1989). In any case, it is considered that the activity of the pathogen is reduced by binding mainly the polyphenol compound contained in the tea extract to the surface of the pathogen of diarrhea in vitro.

【0007】[0007]

【発明が解決しようとする課題】感染性下痢症はヒトお
よび家畜において多大な被害をもたらしている。感染性
下痢症の主たる病原体であるウイルスに対しては、今だ
有効なワクチンが開発されていない。また、病原性細菌
に対しては抗生物質が用いられるが、耐性菌の出現など
の問題点が多い。一方、試験管内の実験により、これら
感染性下痢症の病原体に対して有効な天然物として、現
在、茶抽出物が注目されている。しかし、茶抽出物中の
有効成分であるポリフェノール化合物は、食品中のタン
パク質や多糖類などの高分子物質、あるいは細胞や組織
に非常に吸着しやすい性質を持っている。従って、茶抽
出物をそのまま経口投与したのでは、これらの病原体以
外の他物質に有効成分が吸着してしまい、病原体の感染
部位である腸管まで活性を保ったまま送り届けることが
これまで不可能であった。実際、乳幼児を対象にして、
緑茶がロタウイルス性下痢症に有効かどうかを試験した
結果、予防効果はなかったと報告されている(日本小児
学会総会,1990年)。本発明者らもマウスを使った
動物実験を行ったが、ロタウイルス性下痢症に対する有
効性は実証できなかった。
Infectious diarrhea causes great damage to humans and livestock. No effective vaccine has yet been developed against the virus, the main pathogen of infectious diarrhea. In addition, antibiotics are used for pathogenic bacteria, but there are many problems such as the emergence of resistant bacteria. On the other hand, tea extracts are currently attracting attention as a natural product effective against these pathogens of infectious diarrhea by in vitro experiments. However, the polyphenol compound, which is the active ingredient in the tea extract, has the property of being very easily adsorbed to high molecular substances such as proteins and polysaccharides in foods, or cells and tissues. Therefore, if the tea extract is orally administered as it is, the active ingredient will be adsorbed to substances other than these pathogens, and it has been impossible to deliver it to the intestinal tract, which is the site of infection of the pathogen, while maintaining its activity. there were. In fact, for infants,
As a result of testing whether green tea was effective against rotavirus diarrhea, it was reported that there was no preventive effect (Japan Pediatric Society General Assembly, 1990). The present inventors also conducted animal experiments using mice, but were not able to demonstrate the efficacy against rotavirus diarrhea.

【0008】本発明の目的は、感染性下痢症の病原体に
対して有効な茶成分を、活性を保ったまま腸管まで送り
届けることのできる感染性下痢症予防及び治療用組成物
を提供することにある。
An object of the present invention is to provide a composition for preventing and treating infectious diarrhea, which can deliver a tea component effective against a pathogen of infectious diarrhea to the intestinal tract while maintaining its activity. is there.

【0009】[0009]

【課題を解決するための手段】本発明者らは、前記課題
を解決するために種々研究を重ねた結果、茶抽出物をキ
チンに含有させ、これを経口的に投与することにより、
生体内において初めて、感染性下痢症の予防および治療
に成功した。さらに、茶抽出物を含有するキチンを含む
感染性下痢症予防及び治療用組成物の製造に成功した。
すなわち、本発明は、茶抽出物含有キチンを含む感染性
下痢症予防及び治療用組成物に関する。
Means for Solving the Problems The inventors of the present invention have conducted various studies to solve the above problems, and as a result, a tea extract was contained in chitin and orally administered,
For the first time in vivo, we succeeded in preventing and treating infectious diarrhea. Furthermore, they have succeeded in producing a composition for preventing and treating infectious diarrhea containing chitin containing a tea extract.
That is, the present invention relates to a composition for preventing and treating infectious diarrhea, which comprises chitin containing a tea extract.

【0010】本発明の茶抽出物とは、緑茶などの非発酵
茶、ウーロン茶などの半発酵茶、紅茶などの発酵茶から
水(熱水を含む)、エタノール、メタノール、プロピル
アルコール、アセトン、酢酸エチル、又はヘキサンなど
の溶媒を用いて抽出したものであるが、抽出物をさらに
精製して有効成分であるポリフェノール化合物の純度を
高めたものであっても全く問題ない。例えば、緑茶の熱
水抽出物であるサンフェノン(太陽化学(株)製、登録
商標)をあげることができる。
The tea extract of the present invention means non-fermented tea such as green tea, semi-fermented tea such as oolong tea, fermented tea such as black tea, water (including hot water), ethanol, methanol, propyl alcohol, acetone, acetic acid. It is extracted using a solvent such as ethyl or hexane, but there is no problem even if the extract is further purified to increase the purity of the polyphenol compound as an active ingredient. For example, a hot water extract of green tea, Sanphenon (registered trademark of Taiyo Kagaku Co., Ltd.) can be used.

【0011】本発明のキチンとは、ポリN−アセチル−
D−グルコサミン及びその脱アセチル化物、キトサン、
さらにはキチンと酸類とで形成された塩、例えば酢酸
塩、塩酸塩、硝酸塩、リン酸塩など、またグルコサミン
残基の−OH基又は−CH2 OH基がエステル化、エー
テル化、カルボキシメチル化、ヒドロキシメチル化、あ
るいはO−エチル化されたキチン誘導体も含まれる。
The chitin of the present invention means poly N-acetyl-
D-glucosamine and its deacetylated product, chitosan,
Furthermore, salts formed with chitin and acids, such as acetate, hydrochloride, nitrate, phosphate, etc., -OH group or -CH2 OH group of glucosamine residue is esterified, etherified, carboxymethylated, A hydroxymethylated or O-ethylated chitin derivative is also included.

【0012】前記のポリN−アセチル−D−グルコサミ
ンの脱アセチル化物の場合の脱アセチル化は、ポリN−
アセチル−D−グルコサミンをアルカリ処理するという
公知の方法により行うことができる。この際に使用する
アルカリ濃度、処理温度、処理時間などを適宜変えるこ
とによって、脱アセチル化度を調整することができる。
Deacetylation in the case of the above-mentioned deacetylated product of poly N-acetyl-D-glucosamine is carried out by poly N-
It can be performed by a known method of treating acetyl-D-glucosamine with an alkali. The degree of deacetylation can be adjusted by appropriately changing the alkali concentration, the treatment temperature, the treatment time and the like used at this time.

【0013】本発明に使用するキチンは粉末のままで使
用することもできるし、また成形体として使用すること
もできる。成形体とは例えば繊維、フィブリル、フィル
ム、多孔体、マイクロビーズなどであって、キチン粉末
を適当な溶剤に溶かしドープとし、凝固成形するなど公
知の方法により作成することができる。
The chitin used in the present invention can be used as a powder as it is, or can be used as a molded product. The molded body is, for example, a fiber, fibril, film, porous body, microbead, or the like, and can be prepared by a known method such as dissolving chitin powder in a suitable solvent to form a dope and coagulating and molding.

【0014】本発明の茶抽出物含有キチンとは、キチン
に茶抽出物を吸着あるいは化学的に結合させたものをい
う。またその形態としては粉末状、繊維状、フィブリル
状、フィルム状、多孔体状、マイクロビーズ状などいか
なる形態にも加工できる。
The tea extract-containing chitin of the present invention refers to chitin in which the tea extract is adsorbed or chemically bound. Further, the form thereof can be processed into any form such as powder form, fiber form, fibril form, film form, porous form, and microbead form.

【0015】ポリフェノール類を含む茶抽出物をキチン
に含有させる方法としては、茶抽出物がキチンに吸着ま
たは化学結合できるような混和方法であれば、特に限定
されない。例えば以下のような方法が例示される。 1)茶抽出物を水などの溶媒に溶解し、この溶液にキチ
ンを浸漬した後、乾燥する方法。 2)キチン成形体を成形する際に、茶抽出物を予め練り
込む方法。 3)アルデヒド等の架橋剤を用い、キチン又はキチン成
形体と茶抽出物を結合させる方法。
The method for incorporating the tea extract containing polyphenols into chitin is not particularly limited as long as it is a mixing method capable of adsorbing or chemically binding the tea extract to chitin. For example, the following method is exemplified. 1) A method in which the tea extract is dissolved in a solvent such as water, chitin is immersed in this solution, and then dried. 2) A method in which a tea extract is kneaded in advance when molding a chitin molded body. 3) A method in which a tea extract is combined with chitin or a chitin molded product using a crosslinking agent such as an aldehyde.

【0016】キチンに含有される茶抽出物の濃度は、対
象とする病原体により適宜選択されるため、一定の範囲
に規定されるものではなく、いかなる濃度にも作成でき
る。例えば、多量の茶抽出物を含有したものを必要とす
る場合には、全体の重量に対する茶抽出物の重量を%で
表した場合、50%以上吸着させることも可能である。
Since the concentration of the tea extract contained in chitin is appropriately selected depending on the target pathogen, it is not limited to a certain range and can be prepared at any concentration. For example, when a tea extract containing a large amount of tea extract is required, it is possible to adsorb 50% or more of the tea extract weight based on the total weight.

【0017】本発明でいう感染性下痢症とは、ロタウイ
ルス、コロナウイルス、ノーウオークウイルス、カリシ
ウイルス、アデノウイルス、アストロウイルスなどを病
原体とするウイルス性下痢症、および赤痢菌、サルモネ
ラ菌、病原性大腸菌、毒素原性大腸菌、コレラ菌、腸炎
ビブリオ、エルシニア菌、カンピロバクター属、ヘリコ
バクター属、ブドウ球菌、黄色ブドウ球菌、緑膿菌など
を病原体とする細菌性下痢症をいう。
The infectious diarrhea as referred to in the present invention means viral diarrhea caused by rotavirus, coronavirus, nook virus, calicivirus, adenovirus, astrovirus, etc., and Shigella, Salmonella, pathogenicity. It refers to bacterial diarrhea whose pathogens are Escherichia coli, toxigenic Escherichia coli, cholera, Vibrio parahaemolyticus, Yersinia, Campylobacter, Helicobacter, Staphylococcus, Staphylococcus aureus, Pseudomonas aeruginosa and the like.

【0018】本発明の感染性下痢症予防及び治療用組成
物を投与または給与される対象としては、ヒトまたは家
畜があげられる。ヒトの場合は、感染性下痢症、特にロ
タウイルス性下痢症に罹りやすい3才以下の乳児または
幼児が第一対象となるが、食中毒その他による下痢を起
こす病原体の場合には、成人もその範疇にいれることが
でき、年齢の面で特に限定されない。また家畜の場合
は、下痢症による被害が問題となっている牛、馬、豚、
鶏、羊、山羊を対象とすることができるが、特に哺乳期
の牛、馬、豚はロタウイルス、コロナウイルス、毒素原
性大腸菌などに感染しやすく、被害状況も深刻である。
The subject to which the composition for preventing and treating infectious diarrhea of the present invention is administered or fed includes humans or livestock. In the case of humans, infants and young children under the age of 3 who are prone to infectious diarrhea, especially rotavirus diarrhea, are the primary target, but in the case of pathogens that cause diarrhea due to food poisoning or the like, adults are also in that category. There is no particular limitation in terms of age. In addition, in the case of livestock, cattle, horses, pigs, whose damage due to diarrhea is a problem,
It can target chickens, sheep, and goats, but especially cattle, horses, and pigs in the feeding period are easily infected with rotavirus, coronavirus, toxigenic Escherichia coli, etc., and the damage situation is serious.

【0019】本発明の感染性下痢症予防及び治療用組成
物とは、茶抽出物含有キチンを含むヒト用人工調整乳、
家畜用代用乳、家畜用飼料、食品または医薬品(動物用
医薬品を含む)のことをいう。ヒト用人工調整乳及び家
畜用代用乳の場合は、粉末またはマイクロビーズ状の茶
抽出物含有キチンを人工調整乳粉末または代用乳粉末に
混合し、給与時期に水又は温湯に懸濁して与えればよ
い。家畜用飼料の場合は、茶抽出物含有キチンを通常の
飼料原料と混合した後、必要によりペレット化すればよ
い。食品へ添加する場合は、菓子、パン、ゼリー、プリ
ン、飲料、流動食、経口経管栄養食などの素材に茶抽出
物含有キチンを混合することにより添加することができ
る。医薬品の場合は、茶抽出物含有キチンを一定量含有
した錠剤、顆粒剤又は経口経管栄養剤として投与すれば
よい。
The composition for the prevention and treatment of infectious diarrhea according to the present invention is a human artificial formula containing chitin containing tea extract,
Milk substitute, livestock feed, food or medicine (including veterinary medicine). In the case of human artificial milk preparation and livestock milk substitute, if powdered or microbead-shaped tea extract-containing chitin is mixed with artificial milk powder or milk powder substitute and suspended in water or warm water at the time of feeding Good. In the case of livestock feed, the tea extract-containing chitin may be mixed with a usual feed material and then pelletized if necessary. When it is added to food, it can be added by mixing the tea extract-containing chitin with ingredients such as confectionery, bread, jelly, pudding, beverages, liquid foods, and oral tube-fed foods. In the case of pharmaceuticals, it may be administered as tablets, granules or oral tube feeding agents containing a certain amount of chitin containing tea extract.

【0020】本発明の感染性下痢症予防及び治療用組成
物中の茶抽出物含有キチンの添加量については、感染性
下痢症の予防及び治療に有効な量の茶抽出物が含まれて
いればよく、特に限定されない。さらに詳しく言えば、
感染性下痢症の病原体に有効な成分は茶抽出物中のポリ
フェノール化合物であるため、茶抽出物含有キチンに含
まれるポリフェノール化合物の濃度に合わせて適宜選択
すればよい。以下、実施例及び試験例により本発明をさ
らに詳しく説明するが、本発明はこれらの実施例により
なんら制限されるものではない。
Regarding the added amount of the tea extract-containing chitin in the composition for preventing and treating infectious diarrhea of the present invention, the amount of the tea extract effective for preventing and treating infectious diarrhea is included. It is sufficient and not particularly limited. More specifically,
Since the component effective against the pathogen of infectious diarrhea is the polyphenol compound in the tea extract, it may be appropriately selected according to the concentration of the polyphenol compound contained in the tea extract-containing chitin. Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples, but the present invention is not limited to these Examples.

【0021】[0021]

【実施例】【Example】

実施例1.感染性下痢症予防及び治療用乳幼児調整粉乳
の作製 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチン粉末50gと市販の乳幼児
調整粉乳9,950gを均質に混合し、感染性下痢症予
防及び治療用乳幼児調整粉乳10kgを得た。
Example 1. Preparation of infant formula powder for preventing and treating infectious diarrhea 50 g of tea extract-containing chitin powder containing 50% of sanphenone (manufactured by Taiyo Kagaku Co., Ltd.) as a tea extract and 9,950 g of infant formula powder powder on the market were homogeneously mixed. , 10 kg of infant formula powder for the prevention and treatment of infectious diarrhea was obtained.

【0022】実施例2.感染性下痢症予防及び治療用焼
菓子の作製 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチン粉末を添加した焼菓子(ク
ッキー)を作製した。また、対照としてサンフェノンの
み添加したクッキーも作製し、これらについて官能試験
を行い、比較した。処方を表1に、官能試験の結果を表
2に示す。
Example 2. Preparation of baked confectionery for preventing and treating infectious diarrhea A baked confectionery (cookie) was prepared by adding a tea extract-containing chitin powder containing 50% of sunphenone (manufactured by Taiyo Kagaku) as a tea extract. In addition, as a control, cookies with only added sunphenone were also prepared, and sensory tests were performed on these cookies for comparison. The formulation is shown in Table 1, and the result of the sensory test is shown in Table 2.

【0023】[0023]

【表1】 [Table 1]

【0024】[0024]

【表2】 [Table 2]

【0025】実施例3.感染性下痢症予防及び治療用水
菓子(ゼリー)の作製 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチン粉末を添加した水菓子(ゼ
リー)を作製した。また、対照としてサンフェノンのみ
添加したゼリーも作製し、これらについて官能試験を行
い、比較した。処方を表3に、官能試験の結果を表4に
示す。
Example 3. Preparation of Water Confectionery (Jelly) for Prevention and Treatment of Infectious Diarrhea A water confectionery (jelly) was prepared by adding a tea extract-containing chitin powder containing 50% of sunphenone (manufactured by Taiyo Kagaku Co., Ltd.) as a tea extract. In addition, as a control, jelly containing only sanphenone was also prepared, and a sensory test was performed on these jellies for comparison. The formulation is shown in Table 3, and the result of the sensory test is shown in Table 4.

【0026】[0026]

【表3】 [Table 3]

【0027】[0027]

【表4】 [Table 4]

【0028】実施例4.感染性下痢症予防及び治療用子
豚代用乳の作製 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチン粉末を添加した子豚代用乳
を作製した。処方を表5に示す。
Example 4. Preparation of piglet milk substitute for preventing and treating infectious diarrhea A piglet milk substitute was prepared by adding a tea extract-containing chitin powder containing 50% of sunphenone (manufactured by Taiyo Kagaku) as a tea extract. The prescription is shown in Table 5.

【0029】[0029]

【表5】 [Table 5]

【0030】実施例5.感染性下痢症予防及び治療用錠
剤の作製 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチンを有効成分とする感染性下
痢症予防及び治療用の錠剤を作製した。また、対照とし
てサンフェノンのみ添加した錠剤も作製し、これらにつ
いて官能試験を行い、比較した。処方を表6に、官能試
験の結果を表7に示す。
Example 5. Preparation of Tablet for Preventing and Treating Infectious Diarrhea A tablet for preventing and treating infectious diarrhea containing chitin containing tea extract containing 50% of sanphenone (manufactured by Taiyo Kagaku Co., Ltd.) as a tea extract was prepared. . As a control, tablets to which only sanphenone was added were also prepared, and sensory tests were conducted on these tablets for comparison. The formulation is shown in Table 6 and the result of the sensory test is shown in Table 7.

【0031】[0031]

【表6】 [Table 6]

【0032】[0032]

【表7】 [Table 7]

【0033】実施例6.感染製下痢症予防及び治療用経
口経管栄養食の作製 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチン粉末を添加した経口経管栄
養食を作製した。また、対照としてサンフェノンのみ添
加した経口経管栄養食も作製し、これらについて官能試
験を行い、比較した。処方を表8に、官能試験の結果を
表9に示す。
Example 6. Preparation of Oral Tube-fed Food for Prevention and Treatment of Infectious Diarrhea An oral tube-fed food was prepared by adding chitin powder containing tea extract containing 50% of Sanphenone (manufactured by Taiyo Kagaku Co., Ltd.) as a tea extract. As a control, oral tube-fed nutritional foods containing only sanphenone were also prepared, and sensory tests were conducted on these foods for comparison. The formulation is shown in Table 8 and the result of the sensory test is shown in Table 9.

【0034】[0034]

【表8】 [Table 8]

【0035】[0035]

【表9】 [Table 9]

【0036】試験例1.茶抽出物含有キチンのロタウイ
ルス性下痢症予防効果 茶抽出物としてサンフェノン(太陽化学製)を50%含
有させた茶抽出物含有キチン粉末の懸濁液(40mg/
mlPBS)を50μl生後5日齢のddyマウスに経
口投与した。1時間後、同マウスに対して、ロタウイル
ス4x107 FCFU/mlを含む培養上清液50μl
経口感染させ、その後の下痢発症の有無を5日間観察し
た。また、対照としてサンフェノン20mg/mlPB
Sを経口投与した後、同様の感染実験を行った。その結
果、表10のように茶抽出物含有キチンを投与した群で
は、ロタウイルスによる下痢の発症がほとんど抑制され
たのに対して、キチンを含まないサンフェノンのみ投与
した群では、下痢の予防効果は全くなかった。
Test Example 1. Rotavirus Diarrhea Preventive Effect of Tea Extract-Containing Chitin A suspension of tea extract-containing chitin powder containing 40% of sunphenone (manufactured by Taiyo Kagaku Co., Ltd.) as a tea extract (40 mg /
(50 ml of PBS) was orally administered to 5 day old ddy mice. One hour later, to the same mouse, 50 μl of a culture supernatant containing 4 × 10 7 FCFU / ml of rotavirus.
After oral infection, the onset of diarrhea was observed for 5 days. Also, as a control, Sanphenone 20 mg / ml PB
After oral administration of S, the same infection experiment was performed. As a result, as shown in Table 10, in the group administered with the tea extract-containing chitin, the development of diarrhea caused by rotavirus was almost suppressed, whereas in the group administered with only sunphenone containing no chitin, the diarrhea preventive effect was obtained. There was no.

【0037】[0037]

【表10】 [Table 10]

【0038】試験例2.茶抽出物含有キチンのロタウイ
ルス性下痢症治療効果 試験例1で用いたロタウイルス培養上清液50μlを生
後5日齢のddyマウスに経口感染させた後、1時間後
及び24時間後に試験例1と同じサンプルを50μl経
口投与して、その後の下痢発症の有無を5日間観察し
た。その結果、表11のように茶抽出物含有キチンを投
与した群では下痢が3日目には治癒しているのに対し
て、キチンを含まないサンフェノンのみ投与した群で
は、5日目でも全個体に下痢が見られた。
Test Example 2. Rotavirus diarrhea therapeutic effect of chitin containing tea extract 50 μl of the rotavirus culture supernatant used in Test Example 1 was orally infected to 5-day-old ddy mice, and 1 hour and 24 hours later, Test Example 50 μl of the same sample as 1 was orally administered, and the presence or absence of subsequent diarrhea was observed for 5 days. As a result, as shown in Table 11, diarrhea was cured on the 3rd day in the group administered with the tea extract-containing chitin, whereas all the groups administered with only chiphen-free sanphenone were treated even on the 5th day. Diarrhea was seen in the individual.

【0039】[0039]

【表11】 [Table 11]

【0040】[0040]

【発明の効果】感染性下痢症の主病原体はウイルスと細
菌である。これらの病原体に対して、試験管内の実験か
ら茶抽出物の有効性が指摘されている。しかし、その主
たる有効成分であるポリフェノール化合物は、タンパク
質などに吸着しやすい性質を持っており、そのまま投与
しても感染部位である腸管まで活性を保ったまま送り届
けることができなかった。このような現状において、本
発明では、茶抽出物含有キチンを経口的に生体内へ投与
することにより感染性下痢症の予防及び治療に初めて成
功した。本発明の茶抽出物含有キチンを含む組成物を用
いれば、感染性下痢症を効果的に予防及び治療すること
ができる。
The main pathogens of infectious diarrhea are viruses and bacteria. In vitro experiments have indicated the effectiveness of tea extracts against these pathogens. However, the polyphenol compound, which is the main active ingredient, has a property of being easily adsorbed to proteins and the like, and even if administered as it was, it could not be delivered to the intestinal tract, which is the site of infection, while maintaining its activity. Under such circumstances, the present invention has succeeded in the prevention and treatment of infectious diarrhea for the first time by orally administering chitin containing tea extract into a living body. Use of the composition containing the tea extract-containing chitin of the present invention can effectively prevent and treat infectious diarrhea.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 小笠原 豊 三重県四日市市赤堀新町9番5号 太陽化 学株式会社内 (72)発明者 藤木 優 三重県四日市市赤堀新町9番5号 太陽化 学株式会社内 (72)発明者 金 武祚 三重県四日市市赤堀新町9番5号 太陽化 学株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yutaka Ogasawara 9-5 Akahorishinmachi, Yokkaichi-shi, Mie Solar Chemistry Co., Ltd. (72) Inventor Yu Fujiki 9-5 Akahorishinmachi, Yokkaichi-shi, Mie Solar Chemistry Incorporated (72) Inventor Kim Takehisa 9-5 Akahorishinmachi, Yokkaichi-shi, Mie Solar Engineering Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 茶抽出物含有キチンを含む感染性下痢症
予防及び治療用組成物。
1. A composition for preventing and treating infectious diarrhea, which comprises chitin containing a tea extract.
【請求項2】 感染性下痢症がウイルスを病原体とする
請求項1記載の感染性下痢症予防及び治療用組成物。
2. The composition for preventing and treating infectious diarrhea according to claim 1, wherein the infectious diarrhea is caused by a virus.
【請求項3】 感染性下痢症が細菌を病原体とする請求
項1記載の感染性下痢症予防及び治療用組成物。
3. The composition for preventing and treating infectious diarrhea according to claim 1, wherein the infectious diarrhea is caused by bacteria.
JP22505992A 1992-07-31 1992-07-31 Composition for preventing and treating infectious diarrhea Expired - Lifetime JP3890086B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22505992A JP3890086B2 (en) 1992-07-31 1992-07-31 Composition for preventing and treating infectious diarrhea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22505992A JP3890086B2 (en) 1992-07-31 1992-07-31 Composition for preventing and treating infectious diarrhea

Publications (2)

Publication Number Publication Date
JPH0656689A true JPH0656689A (en) 1994-03-01
JP3890086B2 JP3890086B2 (en) 2007-03-07

Family

ID=16823400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22505992A Expired - Lifetime JP3890086B2 (en) 1992-07-31 1992-07-31 Composition for preventing and treating infectious diarrhea

Country Status (1)

Country Link
JP (1) JP3890086B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294878A (en) * 1994-11-14 1996-05-15 Joan Louise Hibberd Antiviral tea compositions
JPH09169654A (en) * 1995-12-22 1997-06-30 Unitika Ltd Hemostatic agent
WO2003090770A1 (en) * 2002-04-24 2003-11-06 Toyo Shinyaku Co., Ltd. Process for producing proanthocyanidine-rich material
WO2004056205A1 (en) * 2002-12-20 2004-07-08 Unilever N.V. Food compositions for gut health comprising black tea
WO2005020699A1 (en) * 2003-08-29 2005-03-10 Unilever N.V. Tea for gut health
US7863466B2 (en) 2005-04-15 2011-01-04 Toyo Shinyaku Co., Ltd. Method of producing proanthocyanidin-containing material
KR101381971B1 (en) * 2012-03-13 2014-04-10 고려대학교 산학협력단 Antiviral composition for calicivirus comprising rubus coreanus extract

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294878A (en) * 1994-11-14 1996-05-15 Joan Louise Hibberd Antiviral tea compositions
JPH09169654A (en) * 1995-12-22 1997-06-30 Unitika Ltd Hemostatic agent
WO2003090770A1 (en) * 2002-04-24 2003-11-06 Toyo Shinyaku Co., Ltd. Process for producing proanthocyanidine-rich material
WO2004056205A1 (en) * 2002-12-20 2004-07-08 Unilever N.V. Food compositions for gut health comprising black tea
WO2005020699A1 (en) * 2003-08-29 2005-03-10 Unilever N.V. Tea for gut health
US7863466B2 (en) 2005-04-15 2011-01-04 Toyo Shinyaku Co., Ltd. Method of producing proanthocyanidin-containing material
KR101381971B1 (en) * 2012-03-13 2014-04-10 고려대학교 산학협력단 Antiviral composition for calicivirus comprising rubus coreanus extract

Also Published As

Publication number Publication date
JP3890086B2 (en) 2007-03-07

Similar Documents

Publication Publication Date Title
RU2525920C2 (en) Composition of biologically active preventive food additive for young farm animals
KR20030061102A (en) Composition for reducing somatic cell and preventing or treating mastitis of dairy cattle
CN101829124B (en) Veterinary compound sulfadiazine sodium injection and preparation method thereof
JP3890086B2 (en) Composition for preventing and treating infectious diarrhea
KR950011733B1 (en) Disease resistance ration and feed additive for cattles and swines
US11116809B2 (en) Biopolymer compositions for the treatment and prevention of liver disease
JPH1180003A (en) Agent for preventing and treating infectious disease
CN106620668A (en) Compound tilmicosin solid dispersing agent and preparation method thereof
JP3224131B2 (en) Immunostimulatory / infective protective agent containing two or more bacteria, egg white and garlic
US20210128695A1 (en) Ovotransferrin treatment for the reproductive tract
JP6854613B2 (en) Compositions for the prevention and treatment of infectious pneumonia
CN101829129B (en) Veterinary compound gentamycin sulfate injection and preparation method thereof
CN101301280A (en) Sustained release tablet products used as helminthic of livestock
KR100371090B1 (en) The composition of antibacterial complex for animal
RU2524664C1 (en) Method of prevention of mass gastrointestinal and respiratory diseases of suckling pigs
CN101850104B (en) Clindamycin hydrochloride composition medicine
CN109985022B (en) Povidone iodine preparation and its preparing method and use
KR20030021298A (en) The composition of immune enhancer and intestinal regulator for animal
CN111588773B (en) Traditional Chinese medicine composition for preventing and treating newborn piglet diarrhea through sow medicine taking and application thereof
RU2597748C1 (en) Method of increasing resistance of calves to mixed viral-bacterial respiratory infections
RU2681523C2 (en) Composition for the treatment of diarrheal syndrome in intestinal diseases of calves in preweaning period
CN117378706A (en) Feed additive for improving disease resistance of animals and application thereof
Sirsat et al. Effects of dietary chitosan and Neem leaf meal supplementation on intestinal bacterial count in broiler chickens
CN106729658A (en) A kind of amoxicillin solid dispersion and preparation method thereof
WO2014033490A1 (en) Preventive products against pathogenic germs, and method for use thereof

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20031222

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040210

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040308

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040617

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20040622

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050322

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050523

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060725

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060925

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061204

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091208

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091208

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101208

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101208

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111208

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121208

Year of fee payment: 6

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121208

Year of fee payment: 6